A Pilot Study to Evaluate Equol and Its Effects on Menopausal Symptoms Experienced by Women in Singapore
Ang Seng Bin
300 participants
Jul 2, 2025
OBSERVATIONAL
Conditions
Summary
The main aim of this study is to evaluate the effect of equol on menopausal symptoms of women. Our hypothesis is that equol producers will have milder menopausal symptoms compared to non-equol producers. Equol is known as a metabolite produced by gut microbiota from soy-related diet and has estrogen-like activity compared to the isoflavones from soybean. Previous studies have shown that some women can produce equol from soy-related diet, but the others cannot because they don't have the bacteria which can metabolite daidzein in gut even if they take isoflavones thorough soybean products. This study will involve participants consuming a soy protein bar and collection of urine samples before and after its consumption.
Eligibility
Inclusion Criteria1
- \- Women aged 40-60
Exclusion Criteria10
- Pregnant women
- Allergy to Soy
- Allergy to nuts
- Consumed antibiotics within 7 days of the study
- Has a history of autoimmune diseases
- Has a history of thyroid disease
- On medical treatment with hormone therapy, elective oestrogen receptors modulators
- Consuming equol-containing supplements or food
- Consuming painkillers
- Consuming anti-depressants and/or sleeping pills
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The participants will be provided one soy protein bar to consume after dinner on day 1.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07136220